Thomas David Hull III Sells 1,368 Shares of Kewaunee Scientific Co. (NASDAQ:KEQU) Stock

Kewaunee Scientific Co. (NASDAQ:KEQU) CEO Thomas David Hull III sold 1,368 shares of the company’s stock in a transaction dated Friday, January 10th. The stock was sold at an average price of $60.08, for a total transaction of $82,189.44. Following the completion of the transaction, the chief executive officer now owns 41,129 shares in the company, valued at approximately $2,471,030.32. The trade was a 3.22 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

Thomas David Hull III also recently made the following trade(s):

• On Thursday, December 26th, Thomas David Hull III sold 2,000 shares of Kewaunee Scientific stock. The stock was sold at an average price of $63.01, for a total transaction of $126,020.00.

Kewaunee Scientific Trading Up 4.4 %

Shares of NASDAQ:KEQU opened at $58.39 on Thursday. Kewaunee Scientific Co. has a 1 year low of $27.00 and a 1 year high of $67.20. The stock’s fifty day moving average price is $49.63 and its 200-day moving average price is $45.26. The company has a market cap of $167.70 million, a P/E ratio of 9.25 and a beta of 0.72. The company has a debt-to-equity ratio of 0.48, a current ratio of 2.53 and a quick ratio of 2.00.

Analysts Set New Price Targets

Separately, StockNews.com upgraded shares of Kewaunee Scientific from a “hold” rating to a “buy” rating in a report on Wednesday, December 18th.

Institutional Trading of Kewaunee Scientific

A number of institutional investors have recently made changes to their positions in the stock. Ritholtz Wealth Management lifted its position in Kewaunee Scientific by 15.6% during the fourth quarter. Ritholtz Wealth Management now owns 12,619 shares of the technology company’s stock valued at $781,000 after purchasing an additional 1,706 shares during the period. JPMorgan Chase & Co. raised its stake in Kewaunee Scientific by 18,000.0% during the 3rd quarter. JPMorgan Chase & Co. now owns 905 shares of the technology company’s stock valued at $30,000 after buying an additional 900 shares during the last quarter. Barclays PLC bought a new position in shares of Kewaunee Scientific during the 3rd quarter valued at $121,000. Geode Capital Management LLC boosted its stake in shares of Kewaunee Scientific by 8.9% in the 3rd quarter. Geode Capital Management LLC now owns 23,784 shares of the technology company’s stock worth $792,000 after buying an additional 1,941 shares during the last quarter. Finally, State Street Corp bought a new stake in shares of Kewaunee Scientific in the third quarter worth $266,000. Hedge funds and other institutional investors own 32.69% of the company’s stock.

Kewaunee Scientific Company Profile

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.